Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio: 2022-2025

Historic Asset Utilization Ratio for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Sep 2025 value amounting to 0.87.

  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio rose 24.43% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year increase of 24.43%. This contributed to the annual value of 0.76 for FY2024, which is 39.50% up from last year.
  • According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Asset Utilization Ratio is 0.87, which was up 3.67% from 0.84 recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Asset Utilization Ratio registered a high of 0.87 during Q3 2025, and its lowest value of 0.02 during Q4 2022.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Asset Utilization Ratio value was 0.64 (recorded in 2024), while the average stood at 0.55.
  • Data for Kiniksa Pharmaceuticals International's Asset Utilization Ratio shows a peak YoY increase of 2,362.26% (in 2023) and a maximum YoY decrease of 84.90% (in 2023) over the last 5 years.
  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio (Quarterly) stood at 0.02 in 2022, then spiked by 2,362.26% to 0.54 in 2023, then surged by 39.17% to 0.75 in 2024, then rose by 24.43% to 0.87 in 2025.
  • Its last three reported values are 0.87 in Q3 2025, 0.84 for Q2 2025, and 0.82 during Q1 2025.